{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## BlackSheep Cookbook Exploration\n",
    "\n",
    "The Black Sheep Analysis allows researchers to find trends in abnormal protein enrichment among patients in CPTAC datasets. In this Cookbook, we will go through the steps needed to perform a full Black Sheep Analysis."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 1a: Import Dependencies\n",
    "First, import the necessary dependencies and load cptac data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import pandas_profiling\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import cptac\n",
    "import binarization_functionsCopy as bf\n",
    "import blackSheepCPTACmoduleCopy as blsh\n",
    "import gseapy as gp\n",
    "from gseapy.plot import barplot, heatmap, dotplot\n",
    "import requests\n",
    "import json"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 1b: Load Data and Choose Omics Table\n",
    "For this analysis, we will be looking at results across the proteomics, transcriptomics, and phosphoproteomics tables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                    \r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cptac.download(dataset='endometrial')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                    \r"
     ]
    }
   ],
   "source": [
    "en = cptac.Endometrial()\n",
    "proteomics = en.get_proteomics()\n",
    "transcriptomics = en.get_transcriptomics()\n",
    "clinical = en.get_clinical()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Append Genomics_subtype and MSI_status to clinical table\n",
    "df= en.get_derived_molecular()\n",
    "clinical['MSI_status'] = df['MSI_status']\n",
    "clinical['Genomics_subtype'] = df['Genomics_subtype']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2: Determine what attributes you would like to A/B test. \n",
    "For this analysis, we will iteratively go through the various columns in the clinical dataset, to determine if any of them have trends within them for protein enrichment."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Create a copy of the original Clinical DataFrame and drop irrelevant columns.\n",
    "annotations = pd.DataFrame(clinical.copy())\n",
    "annotations = annotations.drop(['Patient_ID', \n",
    "                                'Treatment_naive', \n",
    "                                'Tumor_purity', \n",
    "                                'Gender', \n",
    "                                'Tumor_Site_Other'], axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2a: Binarize column values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_map = {'Tumor':'Normal_Tumor', \n",
    "             'Adjacent_normal':'Other_tumor', \n",
    "             'Enriched_normal':'Other_tumor', \n",
    "             'Myometrium_normal':'Other_tumor'}\n",
    "\n",
    "annotations['Proteomics_Tumor_Normal'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Proteomics_Tumor_Normal', \n",
    "                                                                tumor_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "country_map = {'United States':'US', \n",
    "               'Ukraine':'Other', \n",
    "               'Other_specify':'Other', \n",
    "               'Poland':'Other'}\n",
    "\n",
    "annotations['Country'] = bf.binarizeCategorical(clinical, \n",
    "                                                'Country', \n",
    "                                                country_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['BMI'] = bf.binarizeRange(clinical, 'BMI', 18, 25, \n",
    "                                      'Healthy', 'Unhealthy')\n",
    "\n",
    "annotations['Age'] = bf.binarizeCutOff(clinical, 'Age', \n",
    "                                       60.0, 'Old', 'Young')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "FIGO_map = {'FIGO grade 1':'Low_grade', \n",
    "            'FIGO grade 2':'High_grade', \n",
    "            'FIGO grade 3':'High_grade'}\n",
    "\n",
    "annotations['Histologic_Grade_FIGO'] = bf.binarizeCategorical(clinical, \n",
    "                                                              'Histologic_Grade_FIGO', \n",
    "                                                              FIGO_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "Myo_map = {'under 50 %':'under_50%', \n",
    "           '50 % or more': '50%_or_more', \n",
    "           'Not identified': 'under_50%'}\n",
    "\n",
    "annotations['Myometrial_invasion_Specify'] = bf.binarizeCategorical(clinical, \n",
    "                                                                    'Myometrial_invasion_Specify', \n",
    "                                                                    Myo_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_tumor_map = {'pT1a (FIGO IA)':'Not_FIGO_III', \n",
    "            'pT1b (FIGO IB)':'Not_FIGO_III', \n",
    "            'pT2 (FIGO II)':'Not_FIGO_III', \n",
    "            'pT1 (FIGO I)':'Not_FIGO_III', \n",
    "            'pT3a (FIGO IIIA)':'FIGO_III', \n",
    "            'pT3b (FIGO IIIB)':'FIGO_III'}\n",
    "\n",
    "annotations['Path_Stage_Primary_Tumor-pT'] = bf.binarizeCategorical(clinical, \n",
    "                                                                    'Path_Stage_Primary_Tumor-pT', \n",
    "                                                                    path_tumor_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_lymph_map = {'pN0':'Not_FIGO_III', \n",
    "                  'pNX':'Not_FIGO_III', \n",
    "                  'pN1 (FIGO IIIC1)':'FIGO_III', \n",
    "                  'pN2 (FIGO IIIC2)':'FIGO_III'}\n",
    "\n",
    "annotations['Path_Stage_Reg_Lymph_Nodes-pN'] = bf.binarizeCategorical(clinical, \n",
    "                                                                      'Path_Stage_Reg_Lymph_Nodes-pN', \n",
    "                                                                      path_lymph_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "clin_stage_map = {'cM0':'cM0_or_cM1', \n",
    "                  'cM1':'cM0_or_cM1', \n",
    "                  'Staging Incomplete':'Staging_Incomplete'}\n",
    "\n",
    "annotations['Clin_Stage_Dist_Mets-cM'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Clin_Stage_Dist_Mets-cM', \n",
    "                                                                clin_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_stage_map = {'Staging Incomplete': 'No_distant_metastasis', \n",
    "                  'No pathologic evidence of distant metastasis':'No_distant_metastasis', \n",
    "                  'pM1':'Distant_Metastasis'}\n",
    "\n",
    "annotations['Path_Stage_Dist_Mets-pM'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Path_Stage_Dist_Mets-pM', \n",
    "                                                                path_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_stage_map = {'Stage I':'Stage_I_or_II', \n",
    "                   'Stage II':'Stage_I_or_II', \n",
    "                   'Stage III':'Stage_III_or_IV', \n",
    "                   'Stage IV':'Stage_III_or_IV'}\n",
    "\n",
    "annotations['tumor_Stage-Pathological'] = bf.binarizeCategorical(clinical, \n",
    "                                                               'tumor_Stage-Pathological', \n",
    "                                                               tumor_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "FIGO_stage_map = {'IA':'I_or_II', \n",
    "                  'IB':'I_or_II', \n",
    "                  'II':'I_or_II', \n",
    "                  'IIIA':'III_or_IV', \n",
    "                  'IIIC1':'III_or_IV', \n",
    "                  'IVB':'III_or_IV', \n",
    "                  'IIIC2':'III_or_IV', \n",
    "                  'IIIB':'III_or_IV'}\n",
    "\n",
    "annotations['FIGO_stage'] = bf.binarizeCategorical(clinical, \n",
    "                                                   'FIGO_stage', \n",
    "                                                   FIGO_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "diabetes_map = {'No':'No', \n",
    "                'Yes':'Yes', \n",
    "                'Unknown':'No'}\n",
    "\n",
    "annotations['Diabetes'] = bf.binarizeCategorical(clinical, \n",
    "                                                 'Diabetes', \n",
    "                                                 diabetes_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "race_map = {'White':'White', \n",
    "            'Black or African American':'Not_White', \n",
    "            'Asian':'Not_White', \n",
    "            'Not Reported':'Not_White'}\n",
    "\n",
    "annotations['Race'] = bf.binarizeCategorical(clinical, \n",
    "                                             'Race', \n",
    "                                             race_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "ethnicity_map = {'Not-Hispanic or Latino':'Not_Hispanic', \n",
    "                 'Not reported':'Not_Hispanic', \n",
    "                 'Hispanic or Latino':'Hispanic'}\n",
    "\n",
    "annotations['Ethnicity'] = bf.binarizeCategorical(clinical, \n",
    "                                                  'Ethnicity', \n",
    "                                                  ethnicity_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_site_map = {'Other, specify':'Not_Anterior', \n",
    "                  'Anterior endometrium':'Anterior', \n",
    "                  'Posterior endometrium':'Not_Anterior'}\n",
    "\n",
    "annotations['Tumor_Site'] = bf.binarizeCategorical(clinical, \n",
    "                                                   'Tumor_Site', \n",
    "                                                   tumor_site_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['Tumor_Size_cm'] = bf.binarizeCutOff(clinical, \n",
    "                                                'Tumor_Size_cm', 4.0, \n",
    "                                                'Large_tumor', \n",
    "                                                'Small_tumor')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "num_pregnancies_map = {2:'Less_than_3', \n",
    "                       1:'Less_than_3', \n",
    "                       'None':'Less_than_3', \n",
    "                       None:'Less_than_3', \n",
    "                       3:'3_or_more', \n",
    "                       '4 or more':'3_or_more'}\n",
    "\n",
    "annotations['Num_full_term_pregnancies'] = bf.binarizeCategorical(clinical, \n",
    "                                                                  'Num_full_term_pregnancies', \n",
    "                                                                  num_pregnancies_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "genomics_map = {'MSI-H':'MSI-H', \n",
    "                'CNV_low':'Other_subtype', \n",
    "                'CNV_high':'Other_subtype', \n",
    "                'POLE':'Other_subtype'}\n",
    "\n",
    "annotations['Genomics_subtype'] = bf.binarizeCategorical(clinical, \n",
    "                                                         'Genomics_subtype', \n",
    "                                                         genomics_map)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 3: Perform outliers analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "outliers_prot = blsh.make_outliers_table(transcriptomics, iqrs=1.5, \n",
    "                                         up_or_down='up', \n",
    "                                         aggregate=False, \n",
    "                                         frac_table=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "length = int(len(outliers_prot.index) / 2)\n",
    "only_outliers_up_prot = outliers_prot[:length]\n",
    "outlier_up_prot_dict = {}\n",
    "for i in range(length):\n",
    "    key = proteomics.index[i]\n",
    "    my_filter = only_outliers_up_prot.iloc[i] == 1.0\n",
    "    value = list(only_outliers_up_prot.iloc[i][my_filter].index)\n",
    "    outlier_up_prot_dict[key] = value"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 4: Wrap your A/B test into the outliers analysis, and create a table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "results_prot = blsh.compare_groups_outliers(outliers_prot, \n",
    "                                            annotations)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Many of the output values from compare_group_outliers are NaN, so here we will get rid of the NaN values for visualization purposes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "results_prot = results_prot.dropna(axis=0, how='all')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "sig_cols = []\n",
    "for col in results_prot.columns:\n",
    "    sig_col = bf.significantEnrichments(results_prot, col, 0.01)\n",
    "    if sig_col is not None and len(sig_col) > 5:\n",
    "        sig_cols.append(sig_col)\n",
    "    else:\n",
    "        results_prot = results_prot.drop(col, axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 5: Visualize these enrichments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Daniel\\AppData\\Local\\conda\\conda\\envs\\Research\\lib\\site-packages\\ipykernel_launcher.py:1: MatplotlibDeprecationWarning: Adding an axes using the same arguments as a previous axes currently reuses the earlier instance.  In a future version, a new instance will always be created and returned.  Meanwhile, this warning can be suppressed, and the future behavior ensured, by passing a unique label to each axes instance.\n",
      "  \"\"\"Entry point for launching an IPython kernel.\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAewAAAMVCAYAAAC1KMeYAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<Figure size 468x432 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "axis = plt.axes()\n",
    "sns.heatmap(results_prot, ax = axis)\n",
    "axis.set_title(\"Significantly Up-Regulated Genes in Endometrial Cancer Tumors\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 6: Perform Gene Set Enrichment Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-09-05 17:44:02,970 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                             Term Overlap  \\\n",
      "0   KEGG_2019_Human                                      Endocytosis   2/244   \n",
      "1   KEGG_2019_Human                    Glycosaminoglycan degradation    1/19   \n",
      "2   KEGG_2019_Human         Pentose and glucuronate interconversions    1/34   \n",
      "3   KEGG_2019_Human                                      Ferroptosis    1/40   \n",
      "4   KEGG_2019_Human             Porphyrin and chlorophyll metabolism    1/42   \n",
      "5   KEGG_2019_Human                               Mineral absorption    1/51   \n",
      "6   KEGG_2019_Human            Regulation of lipolysis in adipocytes    1/55   \n",
      "7   KEGG_2019_Human                  Fc epsilon RI signaling pathway    1/68   \n",
      "8   KEGG_2019_Human                  Adipocytokine signaling pathway    1/69   \n",
      "9   KEGG_2019_Human                           ErbB signaling pathway    1/85   \n",
      "10  KEGG_2019_Human                           GnRH signaling pathway    1/93   \n",
      "11  KEGG_2019_Human                T cell receptor signaling pathway   1/101   \n",
      "12  KEGG_2019_Human             Toll-like receptor signaling pathway   1/104   \n",
      "13  KEGG_2019_Human                                  Drug metabolism   1/108   \n",
      "14  KEGG_2019_Human                            TNF signaling pathway   1/110   \n",
      "15  KEGG_2019_Human                   Neurotrophin signaling pathway   1/119   \n",
      "16  KEGG_2019_Human                                         Lysosome   1/123   \n",
      "17  KEGG_2019_Human                       Osteoclast differentiation   1/127   \n",
      "18  KEGG_2019_Human                        Relaxin signaling pathway   1/130   \n",
      "19  KEGG_2019_Human           Fluid shear stress and atherosclerosis   1/139   \n",
      "20  KEGG_2019_Human                                      Necroptosis   1/162   \n",
      "21  KEGG_2019_Human                                      Hepatitis B   1/163   \n",
      "22  KEGG_2019_Human      Protein processing in endoplasmic reticulum   1/165   \n",
      "23  KEGG_2019_Human                                   Tight junction   1/170   \n",
      "24  KEGG_2019_Human                                      Influenza A   1/171   \n",
      "25  KEGG_2019_Human                                       Alcoholism   1/180   \n",
      "26  KEGG_2019_Human  Kaposi sarcoma-associated herpesvirus infection   1/186   \n",
      "27  KEGG_2019_Human                     Epstein-Barr virus infection   1/201   \n",
      "28  KEGG_2019_Human         Human immunodeficiency virus 1 infection   1/212   \n",
      "29  KEGG_2019_Human                           cAMP signaling pathway   1/212   \n",
      "30  KEGG_2019_Human                           MAPK signaling pathway   1/295   \n",
      "31  KEGG_2019_Human          Neuroactive ligand-receptor interaction   1/338   \n",
      "32  KEGG_2019_Human                 Herpes simplex virus 1 infection   1/492   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.012246               1.0            0                     0   11.709602   \n",
      "1   0.013222               1.0            0                     0   75.187970   \n",
      "2   0.023546               1.0            0                     0   42.016807   \n",
      "3   0.027648               1.0            0                     0   35.714286   \n",
      "4   0.029011               1.0            0                     0   34.013605   \n",
      "5   0.035125               1.0            0                     0   28.011204   \n",
      "6   0.037831               1.0            0                     0   25.974026   \n",
      "7   0.046577               1.0            0                     0   21.008403   \n",
      "8   0.047246               1.0            0                     0   20.703934   \n",
      "9   0.057902               1.0            0                     0   16.806723   \n",
      "10  0.063188               1.0            0                     0   15.360983   \n",
      "11  0.068447               1.0            0                     0   14.144272   \n",
      "12  0.070412               1.0            0                     0   13.736264   \n",
      "13  0.073026               1.0            0                     0   13.227513   \n",
      "14  0.074330               1.0            0                     0   12.987013   \n",
      "15  0.080179               1.0            0                     0   12.004802   \n",
      "16  0.082767               1.0            0                     0   11.614402   \n",
      "17  0.085349               1.0            0                     0   11.248594   \n",
      "18  0.087280               1.0            0                     0   10.989011   \n",
      "19  0.093053               1.0            0                     0   10.277492   \n",
      "20  0.107652               1.0            0                     0    8.818342   \n",
      "21  0.108281               1.0            0                     0    8.764242   \n",
      "22  0.109540               1.0            0                     0    8.658009   \n",
      "23  0.112678               1.0            0                     0    8.403361   \n",
      "24  0.113304               1.0            0                     0    8.354219   \n",
      "25  0.118924               1.0            0                     0    7.936508   \n",
      "26  0.122652               1.0            0                     0    7.680492   \n",
      "27  0.131908               1.0            0                     0    7.107321   \n",
      "28  0.138638               1.0            0                     0    6.738544   \n",
      "29  0.138638               1.0            0                     0    6.738544   \n",
      "30  0.187879               1.0            0                     0    4.842615   \n",
      "31  0.212349               1.0            0                     0    4.226543   \n",
      "32  0.294481               1.0            0                     0    2.903600   \n",
      "\n",
      "    Combined Score      Genes  \n",
      "0        51.551753  EHD4;RBSN  \n",
      "1       325.251722       GUSB  \n",
      "2       157.512231       GUSB  \n",
      "3       128.150601       FTH1  \n",
      "4       120.410705       GUSB  \n",
      "5        93.804869       FTH1  \n",
      "6        85.055098        NPY  \n",
      "7        64.425482     MAP2K7  \n",
      "8        63.196222        NPY  \n",
      "9        47.882415     MAP2K7  \n",
      "10       42.421483     MAP2K7  \n",
      "11       37.930681     MAP2K7  \n",
      "12       36.447753     MAP2K7  \n",
      "13       34.615688       GUSB  \n",
      "14       33.756385     MAP2K7  \n",
      "15       30.294105     MAP2K7  \n",
      "16       28.939913       GUSB  \n",
      "17       27.682922     MAP2K7  \n",
      "18       26.798134     MAP2K7  \n",
      "19       24.404796     MAP2K7  \n",
      "20       19.654813       FTH1  \n",
      "21       19.483111     MAP2K7  \n",
      "22       19.146925     MAP2K7  \n",
      "23       18.346400     MAP2K7  \n",
      "24       18.192793     MAP2K7  \n",
      "25       16.898974        NPY  \n",
      "26       16.116776     MAP2K7  \n",
      "27       14.396947     MAP2K7  \n",
      "28       13.314614     MAP2K7  \n",
      "29       13.314614        NPY  \n",
      "30        8.096649     MAP2K7  \n",
      "31        6.549136        NPY  \n",
      "32        3.549774     ZNF605  \n",
      "            Gene_set                               Term Overlap       P-value  \\\n",
      "0    KEGG_2019_Human  Ribosome biogenesis in eukaryotes  20/101  1.734349e-14   \n",
      "1    KEGG_2019_Human                        Spliceosome  21/134  4.867850e-13   \n",
      "2    KEGG_2019_Human          mRNA surveillance pathway   13/91  4.457407e-08   \n",
      "3    KEGG_2019_Human                      RNA transport  17/165  5.744773e-08   \n",
      "4    KEGG_2019_Human           Hepatocellular carcinoma  14/168  1.049896e-05   \n",
      "..               ...                                ...     ...           ...   \n",
      "154  KEGG_2019_Human         Oxytocin signaling pathway   1/153  9.591138e-01   \n",
      "155  KEGG_2019_Human         cGMP-PKG signaling pathway   1/166  9.688747e-01   \n",
      "156  KEGG_2019_Human                       Tuberculosis   1/179  9.763095e-01   \n",
      "157  KEGG_2019_Human             Rap1 signaling pathway   1/206  9.865680e-01   \n",
      "158  KEGG_2019_Human                        Endocytosis   1/244  9.939635e-01   \n",
      "\n",
      "     Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0        5.341794e-12            0                     0    9.612612   \n",
      "1        7.496489e-11            0                     0    7.607593   \n",
      "2        4.576271e-06            0                     0    6.934813   \n",
      "3        4.423475e-06            0                     0    5.001471   \n",
      "4        6.467360e-04            0                     0    4.045307   \n",
      "..                ...          ...                   ...         ...   \n",
      "154      1.000000e+00            0                     0    0.317279   \n",
      "155      1.000000e+00            0                     0    0.292432   \n",
      "156      1.000000e+00            0                     0    0.271194   \n",
      "157      1.000000e+00            0                     0    0.235649   \n",
      "158      1.000000e+00            0                     0    0.198950   \n",
      "\n",
      "     Combined Score                                              Genes  \n",
      "0        304.580979  NOP58;UTP6;CSNK2A1;UTP4;WDR3;RPP40;HEATR1;WDR7...  \n",
      "1        215.682521  SF3B4;TCERG1;AQR;RBM25;SF3B2;EIF4A3;DDX23;PRPF...  \n",
      "2        117.379428  UPF2;UPF1;SMG1;RNGTT;CPSF1;RNMT;CPSF3;EIF4A3;C...  \n",
      "3         83.386477  UPF2;UPF1;GEMIN2;EIF4A3;RPP40;NUP153;CASC3;SEN...  \n",
      "4         46.376352  SMARCE1;SMARCD1;SMARCC1;SMARCB1;PHF10;CDKN2A;A...  \n",
      "..              ...                                                ...  \n",
      "154        0.013245                                               CD38  \n",
      "155        0.009247                                           GTF2IRD1  \n",
      "156        0.006502                                              STAT1  \n",
      "157        0.003187                                              PRKCI  \n",
      "158        0.001205                                              PRKCI  \n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[159 rows x 10 columns]\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-09-05 17:44:11,902 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                                      Term Overlap  \\\n",
      "0  KEGG_2019_Human   Glyoxylate and dicarboxylate metabolism    1/30   \n",
      "1  KEGG_2019_Human  Glycine, serine and threonine metabolism    1/40   \n",
      "2  KEGG_2019_Human                             RNA transport   1/165   \n",
      "\n",
      "    P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0  0.011939               1.0            0                     0   83.333333   \n",
      "1  0.015891               1.0            0                     0   62.500000   \n",
      "2  0.064136               1.0            0                     0   15.151515   \n",
      "\n",
      "   Combined Score Genes  \n",
      "0      368.994341  GLDC  \n",
      "1      258.874854  GLDC  \n",
      "2       41.617414  XPO5  \n"
     ]
    }
   ],
   "source": [
    "for col in sig_cols:\n",
    "    col_name = col.columns[0]\n",
    "    gene_name_list = list(col.index)\n",
    "    enrichment = gp.enrichr(gene_list = gene_name_list, \n",
    "                            description=col_name, \n",
    "                            gene_sets='KEGG_2019_Human',\n",
    "                            outdir='test/endometrial')\n",
    "    print(enrichment.res2d)\n",
    "    barplot(enrichment.res2d, title=col_name)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7: Connect findings with the Genome Druggable Interactive Database (DGIdb)\n",
    "\n",
    "Our goal is to find personalized medicines based on specific clinical attributes, for individual patients, and to see how their current medicines are helping, hurting, or are indifferent towards their cancer treatment."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7a: Personalized Medicine by Clinical Attributes\n",
    "After performing our outlier analyses, we find that there are groups of patients that have a common set of significantly up or down regulated genes grouped by clinical attributes. Here we will use those groups to find drugs best suited to both bring those gene enrichments to normal levels, and aid in the treatment of their cancer\n",
    "\n",
    "First, we will perform HTTP GET requests to DGIdb for all of our significantly up-regulated genes by clinical attribute.  Note, that we will want to look for drugs with an interaction type of 'inhibitor' for up-regulated genes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Here we will link clinical attributes with significantly up-regulated genes\n",
    "sig_genes_up = {}\n",
    "for i, col in enumerate(sig_cols):\n",
    "    list_of_genes = list(col.index)\n",
    "    sig_genes_up[sig_cols[i].columns[0][:-9]] = list_of_genes"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This will perform a general HTTP GET request to DGIdb.  While this is fast, it would be worthwile to search specifically for drugs that are inhibitors to patients' significantly up-regulated genes, so we will compare both queries below."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#General GET Request\n",
    "requests_up = list(map(bf.dgidb_get_request, sig_genes_up.values()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UP-REGULATED GENERAL REQUEST:\n",
      "\n",
      "{\n",
      "    \"Proteomics_Tumor_Normal_Other_tumor\": {\n",
      "        \"FTH1\": {\n",
      "            \"IRON DEXTRAN\": [\n",
      "                \"other\"\n",
      "            ]\n",
      "        },\n",
      "        \"GNLY\": {\n",
      "            \"MYELOPEROXIDASE\": []\n",
      "        },\n",
      "        \"MAP2K7\": {\n",
      "            \"COBIMETINIB\": [\n",
      "                \"allosteric modulator\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Refametinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TRAMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AZD-8330\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SELUMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PD-0325901\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DABRAFENIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BINIMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IODOACETAMIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"WX-554\": []\n",
      "        },\n",
      "        \"NPY\": {\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"ESTRADIOL BENZOATE\": [],\n",
      "            \"BROMOCRIPTINE\": [],\n",
      "            \"ETHER\": [],\n",
      "            \"ROSIGLITAZONE\": [],\n",
      "            \"K-252A\": [],\n",
      "            \"CHEMBL1230906\": []\n",
      "        }\n",
      "    },\n",
      "    \"Histologic_type_Serous\": {\n",
      "        \"ACTL6A\": {\n",
      "            \"CHEMBL225155\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"ARID1A\": {\n",
      "            \"TRASTUZUMAB\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"CHEMBL3287735\": []\n",
      "        },\n",
      "        \"BCL2L1\": {\n",
      "            \"CHEMBL106708\": [],\n",
      "            \"NAVITOCLAX\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISOSORBIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL376408\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"VENETOCLAX\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"OBATOCLAX MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CAD\": {\n",
      "            \"ASPARTIC ACID\": [],\n",
      "            \"PALA\": []\n",
      "        },\n",
      "        \"CARM1\": {\n",
      "            \"CHEMBL468927\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PREGNENOLONE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CBS\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"S-ADENOSYL-L-METHIONINE\": [\n",
      "                \"activator\"\n",
      "            ],\n",
      "            \"SERINE\": [],\n",
      "            \"CYSTEINE\": [],\n",
      "            \"ARSENIC\": []\n",
      "        },\n",
      "        \"CD38\": {\n",
      "            \"DARATUMUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ISATUXIMAB\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"THROMBIN\": [],\n",
      "            \"HuMax-CD38\": [],\n",
      "            \"SAR-650984\": []\n",
      "        },\n",
      "        \"CD40\": {\n",
      "            \"FLUDARABINE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TETANUS TOXOID\": [],\n",
      "            \"DACETUZUMAB\": [\n",
      "                \"antibody\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PG-102\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCATUMUMAB\": [],\n",
      "            \"TENELIXIMAB\": [\n",
      "                \"partial agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK11B\": {\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK12\": {\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDKN2A\": {\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"Ribociclib\": [],\n",
      "            \"Roniciclib\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"ILORASERTIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"CHEMBL1231206\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"GSK-461364\": [],\n",
      "            \"HMN-214\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"IMATINIB\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"ALECTINIB\": [],\n",
      "            \"CRIZOTINIB\": []\n",
      "        },\n",
      "        \"CIP2A\": {\n",
      "            \"GEMCITABINE\": []\n",
      "        },\n",
      "        \"CSNK2A1\": {\n",
      "            \"SILMITASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL92361\": [],\n",
      "            \"CHEMBL270512\": [],\n",
      "            \"RESVERATROL\": [],\n",
      "            \"CHEMBL574060\": [],\n",
      "            \"BENZAMIDINE\": [],\n",
      "            \"CHEMBL572879\": [],\n",
      "            \"CHEMBL1230989\": [],\n",
      "            \"TETRABROMOBENZOTRIAZOLE\": [],\n",
      "            \"CHEMBL376505\": [],\n",
      "            \"CHEMBL222476\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"CHEMBL273101\": [],\n",
      "            \"CHEMBL404508\": [],\n",
      "            \"CHEMBL231095\": [],\n",
      "            \"CHEMBL389767\": [],\n",
      "            \"CHEMBL438303\": [],\n",
      "            \"CHEMBL230347\": [],\n",
      "            \"CHEMBL230137\": [],\n",
      "            \"CHEMBL230354\": [],\n",
      "            \"DICHLORORIBOBENZIMIDAZOLE\": [],\n",
      "            \"QUINALIZARIN\": [],\n",
      "            \"ELLAGIC ACID\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPARIN\": []\n",
      "        },\n",
      "        \"DNMT3A\": {\n",
      "            \"AZACITIDINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DECITABINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IDARUBICIN\": []\n",
      "        },\n",
      "        \"EHMT2\": {\n",
      "            \"CHEMBL569864\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1231795\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL2441082\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"EIF2AK2\": {\n",
      "            \"CHEMBL1802728\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL235641\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INTERFERON ALFA-2B\": []\n",
      "        },\n",
      "        \"ERBB2\": {\n",
      "            \"LAPATINIB\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PERTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"TRASTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"MARGETUXIMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ACALABRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AEE-788\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AFATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AC-480\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BMS-690514\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CP-724714\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CUDC-101\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FALNIDAMOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MUBRITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NERATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Poziotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SAPITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TESEVATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IGN-311\": [],\n",
      "            \"TRASTUZUMAB EMTANSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EVEROLIMUS\": [],\n",
      "            \"FULVESTRANT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"TYRPHOSTIN AG 879\": [],\n",
      "            \"ANTHRAQUINONE\": [],\n",
      "            \"CHLORAMBUCIL\": [],\n",
      "            \"DEPSIPEPTIDE\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"ETHYL NITROSOUREA\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"FILGRASTIM\": [],\n",
      "            \"FLOXURIDINE\": [],\n",
      "            \"ROMIDEPSIN\": [],\n",
      "            \"GEFITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"EPIGALOCATECHIN GALLATE\": [],\n",
      "            \"HYDROCORTISONE\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"ISOFLAVONE\": [],\n",
      "            \"MECHLORETHAMINE HYDROCHLORIDE\": [],\n",
      "            \"CHEMBL35482\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"URACIL\": [],\n",
      "            \"VITAMIN E\": [],\n",
      "            \"CHEMBL2141478\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SB-243213\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INSM-18\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CIMAGLERMIN ALFA\": [],\n",
      "            \"Irbinitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PELITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"T-DM1\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"S-222611\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TAK-285\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LAPATINIB DITOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MOMELOTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITHOCHOLIC ACID\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"GANCICLOVIR\": [],\n",
      "            \"TIPIFARNIB\": [],\n",
      "            \"OSIMERTINIB\": [],\n",
      "            \"ROCILETINIB\": [],\n",
      "            \"MK-2206\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"ANASTROZOLE\": [],\n",
      "            \"EXEMESTANE\": [],\n",
      "            \"GONADORELIN\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"PICTILISIB\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"MM-302\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"VARLITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VS-5584\": [],\n",
      "            \"PKI-179\": [],\n",
      "            \"ARQ-092\": [],\n",
      "            \"BUPARLISIB\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"PONATINIB\": [],\n",
      "            \"SORAFENIB\": [],\n",
      "            \"Pyrotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PA-799\": [],\n",
      "            \"TASELISIB\": [],\n",
      "            \"CUDC-907\": [],\n",
      "            \"IPATASERTIB\": [],\n",
      "            \"COPANLISIB\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"AZD-4547\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"LEUCOVORIN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"BGB-283\": [],\n",
      "            \"TEMSIROLIMUS\": [],\n",
      "            \"DEPATUXIZUMAB MAFODOTIN\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"PILARALISIB (CHEMBL3218575)\": [],\n",
      "            \"CHEMBL1229592\": [],\n",
      "            \"CI-1040\": [],\n",
      "            \"CHEMBL392068\": [],\n",
      "            \"AT-13148\": [],\n",
      "            \"ENTINOSTAT\": [],\n",
      "            \"TRODUSQUEMINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"SUNITINIB\": [],\n",
      "            \"METFORMIN\": [],\n",
      "            \"VINORELBINE BASE\": [],\n",
      "            \"TEGAFUR\": [],\n",
      "            \"LAPULEUCEL-T\": [],\n",
      "            \"RILOTUMUMAB\": [],\n",
      "            \"ONARTUZUMAB\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"SERIBANTUMAB\": [],\n",
      "            \"RAMUCIRUMAB\": [],\n",
      "            \"AZD-8055\": [],\n",
      "            \"BENZONATATE\": [],\n",
      "            \"TIVOZANIB\": [],\n",
      "            \"AFATINIB DIMALEATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OSIMERTINIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Allitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"JNJ-26483327\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MP-412\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Hemay-022\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ERTUMAXOMAB\": [],\n",
      "            \"MDX-210\": [],\n",
      "            \"VANDETANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"FADS1\": {\n",
      "            \"LINOLENIC ACID\": [\n",
      "                \"ligand\"\n",
      "            ],\n",
      "            \"ICOSAPENT\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GANAB\": {\n",
      "            \"MIGLITOL\": [\n",
      "                \"antagonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"GMPS\": {\n",
      "            \"L-GLUTAMATE\": []\n",
      "        },\n",
      "        \"HCK\": {\n",
      "            \"BOSUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1081312\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL306380\": [],\n",
      "            \"CHEMBL286939\": [],\n",
      "            \"QUERCETIN\": [],\n",
      "            \"DASATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENMD-981693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ILORASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"XL-228\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TG100-801\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MASITINIB\": [],\n",
      "            \"NINTEDANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"ILF3\": {\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"INHBA\": {\n",
      "            \"SOTATERCEPT\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KDM2A\": {\n",
      "            \"CHEMBL2164243\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KEAP1\": {\n",
      "            \"DIMETHYL FUMARATE\": [\n",
      "                \"inhibitor\",\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"BARDOXOLONE METHYL\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF11\": {\n",
      "            \"CK0106023\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MONASTROL\": [],\n",
      "            \"CHEMBL205786\": [],\n",
      "            \"CHEMBL228369\": [],\n",
      "            \"CHEMBL481931\": [],\n",
      "            \"(R)-MON-97\": [],\n",
      "            \"CHEMBL205437\": [],\n",
      "            \"CHEMBL204459\": [],\n",
      "            \"CHEMBL380955\": [],\n",
      "            \"FILANESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISPINESIB (CHEMBL228814)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITRONESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF1A\": {\n",
      "            \"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER\": [],\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KIF2C\": {\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KLC3\": {\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"OXALIPLATIN\": []\n",
      "        },\n",
      "        \"MED1\": {\n",
      "            \"BECOCALCIDIOL\": []\n",
      "        },\n",
      "        \"MSH2\": {\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MSH6\": {\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MTHFD2\": {\n",
      "            \"TETRAHYDROFOLATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"CHEMBL1161866\": []\n",
      "        },\n",
      "        \"MYO9B\": {\n",
      "            \"MANNOMUSTINE\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CAPTOPRIL\": [],\n",
      "            \"DIBUCAINE\": [],\n",
      "            \"FELODIPINE\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"VOLANESORSEN SODIUM\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TESTOSTERONE\": [],\n",
      "            \"WORTMANNIN\": [],\n",
      "            \"NIFEDIPINE\": []\n",
      "        },\n",
      "        \"PAK2\": {\n",
      "            \"SELEGILINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PARP1\": {\n",
      "            \"CHEMBL123904\": [],\n",
      "            \"NIACINAMIDE\": [\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"CHEMBL401843\": [],\n",
      "            \"CHEMBL123978\": [],\n",
      "            \"CHEMBL125200\": [],\n",
      "            \"CHEMBL134022\": [],\n",
      "            \"CHEMBL338790\": [],\n",
      "            \"VELIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL452800\": [],\n",
      "            \"CHEMBL361054\": [],\n",
      "            \"OLAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"NIRAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPTANOATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INOSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB TOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB CAMSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PDF\": {\n",
      "            \"CHEMBL431210\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRKCI\": {\n",
      "            \"CEP-2563\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GF-109203\": [],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GSK-690693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"(7S)-HYDROXYL-STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"QUERCETIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MIDOSTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INGENOL MEBUTATE\": [],\n",
      "            \"SOTRASTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        },\n",
      "        \"SMARCA4\": {\n",
      "            \"TRETINOIN\": [],\n",
      "            \"VINORELBINE BASE\": []\n",
      "        },\n",
      "        \"SMARCA5\": {\n",
      "            \"DEXTROSE\": []\n",
      "        },\n",
      "        \"SMARCB1\": {\n",
      "            \"PANOBINOSTAT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"FENRETINIDE\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"PENTANAL\": []\n",
      "        },\n",
      "        \"STAT2\": {\n",
      "            \"ISOTRETINOIN\": []\n",
      "        },\n",
      "        \"THBS2\": {\n",
      "            \"CORTICOTROPIN\": [],\n",
      "            \"BEVACIZUMAB\": []\n",
      "        },\n",
      "        \"TK1\": {\n",
      "            \"THYMIDINE_TRIPHOSPHATE\": []\n",
      "        },\n",
      "        \"TNFSF10\": {\n",
      "            \"SODIUM BUTYRATE\": [],\n",
      "            \"TRICHOSTATIN\": []\n",
      "        },\n",
      "        \"TOP1\": {\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"EDOTECARIN\": [],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"7-ETHYL-10-HYDROXY-CAMPTOTHECIN\": [],\n",
      "            \"SODIUM STIBOGLUCONATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"KARENITECIN\": [],\n",
      "            \"CHEMBL343336\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETIRINOTECAN PEGOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IRINOTECAN SUCROSOFATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LURTOTECAN\": [],\n",
      "            \"IRINOTECAN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [],\n",
      "            \"RUBITECAN\": [],\n",
      "            \"IRINOTECAN HYDROCHLORIDE HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TOP2A\": {\n",
      "            \"TENIPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMSACRINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VALRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EPIRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TROVAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LOMEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NORFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LEVOFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PODOFILOX\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SPARFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GENISTEIN\": [],\n",
      "            \"FLEROXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BANOXANTRONE\": [],\n",
      "            \"AMONAFIDE\": [],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"BERUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FINAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"DEXRAZOXANE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"VINCRISTINE\": [],\n",
      "            \"VOSAROXIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ALDOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MM-302\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE PHOSPHATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN CITRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDARUBICIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACTINOMYCIN\": [],\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"IDARUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDRONOXIL\": []\n",
      "        },\n",
      "        \"TP53\": {\n",
      "            \"TARENFLURBIL\": [],\n",
      "            \"ASPIRIN\": [\n",
      "                \"acetylation\"\n",
      "            ],\n",
      "            \"Lesogaberan\": [],\n",
      "            \"CHEMBL1235116\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"ENALAPRIL\": [],\n",
      "            \"RIZATRIPTAN\": [],\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"INOSITOL\": [],\n",
      "            \"INTERFERON ALFA-2B\": [],\n",
      "            \"CHEMBL1221512\": [],\n",
      "            \"METHIMAZOLE\": [],\n",
      "            \"METHYLPREDNISOLONE\": [],\n",
      "            \"MYCOPHENOLIC ACID\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"PUROMYCIN\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"RITUXIMAB\": [],\n",
      "            \"STREPTONIGRIN\": [],\n",
      "            \"TIRAPAZAMINE\": [],\n",
      "            \"THIOTEPA\": [],\n",
      "            \"TRIFLUOPERAZINE\": [],\n",
      "            \"URSODIOL\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"VESNARINONE\": [],\n",
      "            \"YONDELIS\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"GARLIC\": [],\n",
      "            \"GOSSYPOL\": [],\n",
      "            \"GRANISETRON\": [],\n",
      "            \"ZINC CHLORIDE\": [],\n",
      "            \"BORTEZOMIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"AZD-6738\": [],\n",
      "            \"DECITABINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"MITOMYCIN\": [],\n",
      "            \"AZD-1775\": [],\n",
      "            \"PRAMLINTIDE\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"GANETESPIB\": [],\n",
      "            \"SELICICLIB\": [],\n",
      "            \"Tepotinib\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"DEMCIZUMAB\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"PD-0325901\": [],\n",
      "            \"VX-970\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"ENCORAFENIB\": [],\n",
      "            \"NAVITOCLAX\": [],\n",
      "            \"DABRAFENIB\": [],\n",
      "            \"PF-04217903\": [],\n",
      "            \"DACTOLISIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"CHEMBL376408\": [],\n",
      "            \"ALPELISIB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"CYTARABINE\": [],\n",
      "            \"NUTLIN-3\": [],\n",
      "            \"PAZOPANIB\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"HEMICHOLINIUM-3\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"PRODIGIOSIN\": [],\n",
      "            \"TRIFLURIDINE\": [],\n",
      "            \"RG-547\": [],\n",
      "            \"LY-3009120\": [],\n",
      "            \"VEMURAFENIB\": [],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"DS-7423\": [],\n",
      "            \"LORLATINIB\": [],\n",
      "            \"SP-600125\": [],\n",
      "            \"PHA-680632\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5363\": [],\n",
      "            \"CAPMATINIB\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"TANESPIMYCIN\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"AMG-900\": [],\n",
      "            \"AZD-6482\": [],\n",
      "            \"IBRUTINIB\": [],\n",
      "            \"ALVESPIMYCIN\": [],\n",
      "            \"PIMASERTIB\": [],\n",
      "            \"CHEMBL303958\": [],\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"RG-7602\": [],\n",
      "            \"ETOPOSIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"DUVELISIB\": [],\n",
      "            \"AZD-7762\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"CHEMBL392068\": []\n",
      "        },\n",
      "        \"TPX2\": {\n",
      "            \"N (g)-NITRO-L-ARGININE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TUBB4A\": {\n",
      "            \"EPOTHILONE D\": [],\n",
      "            \"PATUPILONE\": [],\n",
      "            \"LEXIBULIN\": []\n",
      "        },\n",
      "        \"VCAM1\": {\n",
      "            \"CARVEDILOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SUCCINOBUCOL\": [],\n",
      "            \"DEXAMETHASONE\": [],\n",
      "            \"PHORBOL MYRISTATE ACETATE\": [],\n",
      "            \"TROGLITAZONE\": [],\n",
      "            \"MERCAPTOPURINE\": [],\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"WNT7A\": {\n",
      "            \"DIETHYLSTILBESTROL\": []\n",
      "        },\n",
      "        \"XPO1\": {\n",
      "            \"SELINEXOR\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        }\n",
      "    },\n",
      "    \"LVSI_1.0\": {\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"HAPLN1\": {\n",
      "            \"HYALURONIC ACID\": [\n",
      "                \"binder\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        }\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "} \n",
      "\n"
     ]
    }
   ],
   "source": [
    "print('UP-REGULATED GENERAL REQUEST:\\n')\n",
    "drug_dict_up = {}\n",
    "for i, request in enumerate(requests_up):\n",
    "    clinical_attribute = sig_cols[i].columns[0][:-9]\n",
    "    drug_dict_up[clinical_attribute] = bf.dgidb_json_parse(request, genes=True)\n",
    "print(json.dumps(drug_dict_up, indent=4), '\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "inhibitors = []\n",
    "for genes in sig_genes_up.values():\n",
    "    inhibitors.append(bf.dgidb_get_request(genes, interaction_types=['inhibitor']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UP-REGULATED INHIBITORS:\n",
      "\n",
      "{\n",
      "    \"Proteomics_Tumor_Normal_Other_tumor\": {\n",
      "        \"FTH1\": {\n",
      "            \"IRON DEXTRAN\": [\n",
      "                \"other\"\n",
      "            ]\n",
      "        },\n",
      "        \"GNLY\": {\n",
      "            \"MYELOPEROXIDASE\": []\n",
      "        },\n",
      "        \"MAP2K7\": {\n",
      "            \"COBIMETINIB\": [\n",
      "                \"allosteric modulator\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Refametinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TRAMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AZD-8330\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SELUMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PD-0325901\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DABRAFENIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BINIMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IODOACETAMIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"WX-554\": []\n",
      "        },\n",
      "        \"NPY\": {\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"ESTRADIOL BENZOATE\": [],\n",
      "            \"BROMOCRIPTINE\": [],\n",
      "            \"ETHER\": [],\n",
      "            \"ROSIGLITAZONE\": [],\n",
      "            \"K-252A\": [],\n",
      "            \"CHEMBL1230906\": []\n",
      "        }\n",
      "    },\n",
      "    \"Histologic_type_Serous\": {\n",
      "        \"ACTL6A\": {\n",
      "            \"CHEMBL225155\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"ARID1A\": {\n",
      "            \"TRASTUZUMAB\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"CHEMBL3287735\": []\n",
      "        },\n",
      "        \"BCL2L1\": {\n",
      "            \"CHEMBL106708\": [],\n",
      "            \"NAVITOCLAX\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISOSORBIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL376408\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"VENETOCLAX\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"OBATOCLAX MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CAD\": {\n",
      "            \"ASPARTIC ACID\": [],\n",
      "            \"PALA\": []\n",
      "        },\n",
      "        \"CARM1\": {\n",
      "            \"CHEMBL468927\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PREGNENOLONE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CBS\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"S-ADENOSYL-L-METHIONINE\": [\n",
      "                \"activator\"\n",
      "            ],\n",
      "            \"SERINE\": [],\n",
      "            \"CYSTEINE\": [],\n",
      "            \"ARSENIC\": []\n",
      "        },\n",
      "        \"CD38\": {\n",
      "            \"DARATUMUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ISATUXIMAB\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"THROMBIN\": [],\n",
      "            \"HuMax-CD38\": [],\n",
      "            \"SAR-650984\": []\n",
      "        },\n",
      "        \"CD40\": {\n",
      "            \"FLUDARABINE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TETANUS TOXOID\": [],\n",
      "            \"DACETUZUMAB\": [\n",
      "                \"antibody\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PG-102\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCATUMUMAB\": [],\n",
      "            \"TENELIXIMAB\": [\n",
      "                \"partial agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK11B\": {\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK12\": {\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDKN2A\": {\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"Ribociclib\": [],\n",
      "            \"Roniciclib\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"ILORASERTIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"CHEMBL1231206\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"GSK-461364\": [],\n",
      "            \"HMN-214\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"IMATINIB\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"ALECTINIB\": [],\n",
      "            \"CRIZOTINIB\": []\n",
      "        },\n",
      "        \"CIP2A\": {\n",
      "            \"GEMCITABINE\": []\n",
      "        },\n",
      "        \"CSNK2A1\": {\n",
      "            \"SILMITASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL92361\": [],\n",
      "            \"CHEMBL270512\": [],\n",
      "            \"RESVERATROL\": [],\n",
      "            \"CHEMBL574060\": [],\n",
      "            \"BENZAMIDINE\": [],\n",
      "            \"CHEMBL572879\": [],\n",
      "            \"CHEMBL1230989\": [],\n",
      "            \"TETRABROMOBENZOTRIAZOLE\": [],\n",
      "            \"CHEMBL376505\": [],\n",
      "            \"CHEMBL222476\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"CHEMBL273101\": [],\n",
      "            \"CHEMBL404508\": [],\n",
      "            \"CHEMBL231095\": [],\n",
      "            \"CHEMBL389767\": [],\n",
      "            \"CHEMBL438303\": [],\n",
      "            \"CHEMBL230347\": [],\n",
      "            \"CHEMBL230137\": [],\n",
      "            \"CHEMBL230354\": [],\n",
      "            \"DICHLORORIBOBENZIMIDAZOLE\": [],\n",
      "            \"QUINALIZARIN\": [],\n",
      "            \"ELLAGIC ACID\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPARIN\": []\n",
      "        },\n",
      "        \"DNMT3A\": {\n",
      "            \"AZACITIDINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DECITABINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IDARUBICIN\": []\n",
      "        },\n",
      "        \"EHMT2\": {\n",
      "            \"CHEMBL569864\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1231795\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL2441082\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"EIF2AK2\": {\n",
      "            \"CHEMBL1802728\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL235641\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INTERFERON ALFA-2B\": []\n",
      "        },\n",
      "        \"ERBB2\": {\n",
      "            \"LAPATINIB\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PERTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"TRASTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"MARGETUXIMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ACALABRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AEE-788\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AFATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AC-480\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BMS-690514\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CP-724714\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CUDC-101\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FALNIDAMOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MUBRITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NERATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Poziotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SAPITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TESEVATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IGN-311\": [],\n",
      "            \"TRASTUZUMAB EMTANSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EVEROLIMUS\": [],\n",
      "            \"FULVESTRANT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"TYRPHOSTIN AG 879\": [],\n",
      "            \"ANTHRAQUINONE\": [],\n",
      "            \"CHLORAMBUCIL\": [],\n",
      "            \"DEPSIPEPTIDE\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"ETHYL NITROSOUREA\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"FILGRASTIM\": [],\n",
      "            \"FLOXURIDINE\": [],\n",
      "            \"ROMIDEPSIN\": [],\n",
      "            \"GEFITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"EPIGALOCATECHIN GALLATE\": [],\n",
      "            \"HYDROCORTISONE\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"ISOFLAVONE\": [],\n",
      "            \"MECHLORETHAMINE HYDROCHLORIDE\": [],\n",
      "            \"CHEMBL35482\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"URACIL\": [],\n",
      "            \"VITAMIN E\": [],\n",
      "            \"CHEMBL2141478\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SB-243213\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INSM-18\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CIMAGLERMIN ALFA\": [],\n",
      "            \"Irbinitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PELITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"T-DM1\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"S-222611\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TAK-285\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LAPATINIB DITOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MOMELOTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITHOCHOLIC ACID\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"GANCICLOVIR\": [],\n",
      "            \"TIPIFARNIB\": [],\n",
      "            \"OSIMERTINIB\": [],\n",
      "            \"ROCILETINIB\": [],\n",
      "            \"MK-2206\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"ANASTROZOLE\": [],\n",
      "            \"EXEMESTANE\": [],\n",
      "            \"GONADORELIN\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"PICTILISIB\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"MM-302\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"VARLITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VS-5584\": [],\n",
      "            \"PKI-179\": [],\n",
      "            \"ARQ-092\": [],\n",
      "            \"BUPARLISIB\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"PONATINIB\": [],\n",
      "            \"SORAFENIB\": [],\n",
      "            \"Pyrotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PA-799\": [],\n",
      "            \"TASELISIB\": [],\n",
      "            \"CUDC-907\": [],\n",
      "            \"IPATASERTIB\": [],\n",
      "            \"COPANLISIB\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"AZD-4547\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"LEUCOVORIN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"BGB-283\": [],\n",
      "            \"TEMSIROLIMUS\": [],\n",
      "            \"DEPATUXIZUMAB MAFODOTIN\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"PILARALISIB (CHEMBL3218575)\": [],\n",
      "            \"CHEMBL1229592\": [],\n",
      "            \"CI-1040\": [],\n",
      "            \"CHEMBL392068\": [],\n",
      "            \"AT-13148\": [],\n",
      "            \"ENTINOSTAT\": [],\n",
      "            \"TRODUSQUEMINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"SUNITINIB\": [],\n",
      "            \"METFORMIN\": [],\n",
      "            \"VINORELBINE BASE\": [],\n",
      "            \"TEGAFUR\": [],\n",
      "            \"LAPULEUCEL-T\": [],\n",
      "            \"RILOTUMUMAB\": [],\n",
      "            \"ONARTUZUMAB\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"SERIBANTUMAB\": [],\n",
      "            \"RAMUCIRUMAB\": [],\n",
      "            \"AZD-8055\": [],\n",
      "            \"BENZONATATE\": [],\n",
      "            \"TIVOZANIB\": [],\n",
      "            \"AFATINIB DIMALEATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OSIMERTINIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Allitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"JNJ-26483327\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MP-412\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Hemay-022\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ERTUMAXOMAB\": [],\n",
      "            \"MDX-210\": [],\n",
      "            \"VANDETANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"FADS1\": {\n",
      "            \"LINOLENIC ACID\": [\n",
      "                \"ligand\"\n",
      "            ],\n",
      "            \"ICOSAPENT\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GANAB\": {\n",
      "            \"MIGLITOL\": [\n",
      "                \"antagonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"GMPS\": {\n",
      "            \"L-GLUTAMATE\": []\n",
      "        },\n",
      "        \"HCK\": {\n",
      "            \"BOSUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1081312\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL306380\": [],\n",
      "            \"CHEMBL286939\": [],\n",
      "            \"QUERCETIN\": [],\n",
      "            \"DASATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENMD-981693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ILORASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"XL-228\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TG100-801\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MASITINIB\": [],\n",
      "            \"NINTEDANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"ILF3\": {\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"INHBA\": {\n",
      "            \"SOTATERCEPT\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KDM2A\": {\n",
      "            \"CHEMBL2164243\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KEAP1\": {\n",
      "            \"DIMETHYL FUMARATE\": [\n",
      "                \"inhibitor\",\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"BARDOXOLONE METHYL\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF11\": {\n",
      "            \"CK0106023\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MONASTROL\": [],\n",
      "            \"CHEMBL205786\": [],\n",
      "            \"CHEMBL228369\": [],\n",
      "            \"CHEMBL481931\": [],\n",
      "            \"(R)-MON-97\": [],\n",
      "            \"CHEMBL205437\": [],\n",
      "            \"CHEMBL204459\": [],\n",
      "            \"CHEMBL380955\": [],\n",
      "            \"FILANESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISPINESIB (CHEMBL228814)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITRONESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF1A\": {\n",
      "            \"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER\": [],\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KIF2C\": {\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KLC3\": {\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"OXALIPLATIN\": []\n",
      "        },\n",
      "        \"MED1\": {\n",
      "            \"BECOCALCIDIOL\": []\n",
      "        },\n",
      "        \"MSH2\": {\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MSH6\": {\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MTHFD2\": {\n",
      "            \"TETRAHYDROFOLATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"CHEMBL1161866\": []\n",
      "        },\n",
      "        \"MYO9B\": {\n",
      "            \"MANNOMUSTINE\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CAPTOPRIL\": [],\n",
      "            \"DIBUCAINE\": [],\n",
      "            \"FELODIPINE\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"VOLANESORSEN SODIUM\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TESTOSTERONE\": [],\n",
      "            \"WORTMANNIN\": [],\n",
      "            \"NIFEDIPINE\": []\n",
      "        },\n",
      "        \"PAK2\": {\n",
      "            \"SELEGILINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PARP1\": {\n",
      "            \"CHEMBL123904\": [],\n",
      "            \"NIACINAMIDE\": [\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"CHEMBL401843\": [],\n",
      "            \"CHEMBL123978\": [],\n",
      "            \"CHEMBL125200\": [],\n",
      "            \"CHEMBL134022\": [],\n",
      "            \"CHEMBL338790\": [],\n",
      "            \"VELIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL452800\": [],\n",
      "            \"CHEMBL361054\": [],\n",
      "            \"OLAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"NIRAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPTANOATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INOSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB TOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB CAMSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PDF\": {\n",
      "            \"CHEMBL431210\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRKCI\": {\n",
      "            \"CEP-2563\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GF-109203\": [],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GSK-690693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"(7S)-HYDROXYL-STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"QUERCETIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MIDOSTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INGENOL MEBUTATE\": [],\n",
      "            \"SOTRASTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        },\n",
      "        \"SMARCA4\": {\n",
      "            \"TRETINOIN\": [],\n",
      "            \"VINORELBINE BASE\": []\n",
      "        },\n",
      "        \"SMARCA5\": {\n",
      "            \"DEXTROSE\": []\n",
      "        },\n",
      "        \"SMARCB1\": {\n",
      "            \"PANOBINOSTAT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"FENRETINIDE\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"PENTANAL\": []\n",
      "        },\n",
      "        \"STAT2\": {\n",
      "            \"ISOTRETINOIN\": []\n",
      "        },\n",
      "        \"THBS2\": {\n",
      "            \"CORTICOTROPIN\": [],\n",
      "            \"BEVACIZUMAB\": []\n",
      "        },\n",
      "        \"TK1\": {\n",
      "            \"THYMIDINE_TRIPHOSPHATE\": []\n",
      "        },\n",
      "        \"TNFSF10\": {\n",
      "            \"SODIUM BUTYRATE\": [],\n",
      "            \"TRICHOSTATIN\": []\n",
      "        },\n",
      "        \"TOP1\": {\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"EDOTECARIN\": [],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"7-ETHYL-10-HYDROXY-CAMPTOTHECIN\": [],\n",
      "            \"SODIUM STIBOGLUCONATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"KARENITECIN\": [],\n",
      "            \"CHEMBL343336\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETIRINOTECAN PEGOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IRINOTECAN SUCROSOFATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LURTOTECAN\": [],\n",
      "            \"IRINOTECAN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [],\n",
      "            \"RUBITECAN\": [],\n",
      "            \"IRINOTECAN HYDROCHLORIDE HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TOP2A\": {\n",
      "            \"TENIPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMSACRINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VALRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EPIRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TROVAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LOMEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NORFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LEVOFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PODOFILOX\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SPARFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GENISTEIN\": [],\n",
      "            \"FLEROXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BANOXANTRONE\": [],\n",
      "            \"AMONAFIDE\": [],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"BERUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FINAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"DEXRAZOXANE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"VINCRISTINE\": [],\n",
      "            \"VOSAROXIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ALDOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MM-302\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE PHOSPHATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN CITRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDARUBICIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACTINOMYCIN\": [],\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"IDARUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDRONOXIL\": []\n",
      "        },\n",
      "        \"TP53\": {\n",
      "            \"TARENFLURBIL\": [],\n",
      "            \"ASPIRIN\": [\n",
      "                \"acetylation\"\n",
      "            ],\n",
      "            \"Lesogaberan\": [],\n",
      "            \"CHEMBL1235116\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"ENALAPRIL\": [],\n",
      "            \"RIZATRIPTAN\": [],\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"INOSITOL\": [],\n",
      "            \"INTERFERON ALFA-2B\": [],\n",
      "            \"CHEMBL1221512\": [],\n",
      "            \"METHIMAZOLE\": [],\n",
      "            \"METHYLPREDNISOLONE\": [],\n",
      "            \"MYCOPHENOLIC ACID\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"PUROMYCIN\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"RITUXIMAB\": [],\n",
      "            \"STREPTONIGRIN\": [],\n",
      "            \"TIRAPAZAMINE\": [],\n",
      "            \"THIOTEPA\": [],\n",
      "            \"TRIFLUOPERAZINE\": [],\n",
      "            \"URSODIOL\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"VESNARINONE\": [],\n",
      "            \"YONDELIS\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"GARLIC\": [],\n",
      "            \"GOSSYPOL\": [],\n",
      "            \"GRANISETRON\": [],\n",
      "            \"ZINC CHLORIDE\": [],\n",
      "            \"BORTEZOMIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"AZD-6738\": [],\n",
      "            \"DECITABINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"MITOMYCIN\": [],\n",
      "            \"AZD-1775\": [],\n",
      "            \"PRAMLINTIDE\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"GANETESPIB\": [],\n",
      "            \"SELICICLIB\": [],\n",
      "            \"Tepotinib\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"DEMCIZUMAB\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"PD-0325901\": [],\n",
      "            \"VX-970\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"ENCORAFENIB\": [],\n",
      "            \"NAVITOCLAX\": [],\n",
      "            \"DABRAFENIB\": [],\n",
      "            \"PF-04217903\": [],\n",
      "            \"DACTOLISIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"CHEMBL376408\": [],\n",
      "            \"ALPELISIB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"CYTARABINE\": [],\n",
      "            \"NUTLIN-3\": [],\n",
      "            \"PAZOPANIB\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"HEMICHOLINIUM-3\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"PRODIGIOSIN\": [],\n",
      "            \"TRIFLURIDINE\": [],\n",
      "            \"RG-547\": [],\n",
      "            \"LY-3009120\": [],\n",
      "            \"VEMURAFENIB\": [],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"DS-7423\": [],\n",
      "            \"LORLATINIB\": [],\n",
      "            \"SP-600125\": [],\n",
      "            \"PHA-680632\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5363\": [],\n",
      "            \"CAPMATINIB\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"TANESPIMYCIN\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"AMG-900\": [],\n",
      "            \"AZD-6482\": [],\n",
      "            \"IBRUTINIB\": [],\n",
      "            \"ALVESPIMYCIN\": [],\n",
      "            \"PIMASERTIB\": [],\n",
      "            \"CHEMBL303958\": [],\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"RG-7602\": [],\n",
      "            \"ETOPOSIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"DUVELISIB\": [],\n",
      "            \"AZD-7762\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"CHEMBL392068\": []\n",
      "        },\n",
      "        \"TPX2\": {\n",
      "            \"N (g)-NITRO-L-ARGININE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TUBB4A\": {\n",
      "            \"EPOTHILONE D\": [],\n",
      "            \"PATUPILONE\": [],\n",
      "            \"LEXIBULIN\": []\n",
      "        },\n",
      "        \"VCAM1\": {\n",
      "            \"CARVEDILOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SUCCINOBUCOL\": [],\n",
      "            \"DEXAMETHASONE\": [],\n",
      "            \"PHORBOL MYRISTATE ACETATE\": [],\n",
      "            \"TROGLITAZONE\": [],\n",
      "            \"MERCAPTOPURINE\": [],\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"WNT7A\": {\n",
      "            \"DIETHYLSTILBESTROL\": []\n",
      "        },\n",
      "        \"XPO1\": {\n",
      "            \"SELINEXOR\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        }\n",
      "    },\n",
      "    \"LVSI_1.0\": {\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"HAPLN1\": {\n",
      "            \"HYALURONIC ACID\": [\n",
      "                \"binder\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        }\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "}\n"
     ]
    }
   ],
   "source": [
    "print('UP-REGULATED INHIBITORS:\\n')\n",
    "inhibitor_dict = {}\n",
    "for i, request in enumerate(requests_up):\n",
    "    clinical_attribute = sig_cols[i].columns[0][:-9]\n",
    "    inhibitor_dict[clinical_attribute] = bf.dgidb_json_parse(request, genes=True)\n",
    "print(json.dumps(inhibitor_dict, indent=4))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7b: Compare patients' significant genes with the drugs they are currently taking"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Patient_ID',\n",
       " 'Proteomics_Tumor_Normal',\n",
       " 'Country',\n",
       " 'Histologic_Grade_FIGO',\n",
       " 'Myometrial_invasion_Specify',\n",
       " 'Histologic_type',\n",
       " 'Treatment_naive',\n",
       " 'Tumor_purity',\n",
       " 'Path_Stage_Primary_Tumor-pT',\n",
       " 'Path_Stage_Reg_Lymph_Nodes-pN',\n",
       " 'Clin_Stage_Dist_Mets-cM',\n",
       " 'Path_Stage_Dist_Mets-pM',\n",
       " 'tumor_Stage-Pathological',\n",
       " 'FIGO_stage',\n",
       " 'LVSI',\n",
       " 'BMI',\n",
       " 'Age',\n",
       " 'Diabetes',\n",
       " 'Race',\n",
       " 'Ethnicity',\n",
       " 'Gender',\n",
       " 'Tumor_Site',\n",
       " 'Tumor_Site_Other',\n",
       " 'Tumor_Focality',\n",
       " 'Tumor_Size_cm',\n",
       " 'Num_full_term_pregnancies',\n",
       " 'MSI_status',\n",
       " 'Genomics_subtype']"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(clinical.columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"\\nThis cell is not working because I need to still connect the drugs that patients\\nare taking with the clinical dataframe somehow. I'll need to merge dataframes\\nmost likely.  Additionally, I will probably need to rework my function to include\\nan arg for medication_col_name or something like that to work on multiple datasets\\nand not just for Renal\\n\""
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "'''\n",
    "This cell is not working because I need to still connect the drugs that patients\n",
    "are taking with the clinical dataframe somehow. I'll need to merge dataframes\n",
    "most likely.  Additionally, I will probably need to rework my function to include\n",
    "an arg for medication_col_name or something like that to work on multiple datasets\n",
    "and not just for Renal\n",
    "'''\n",
    "#patient_drugs_genes_up = bf.compare_enrichments_with_drugs(outlier_up_prot_dict, clinical)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "follow_up_df = pd.read_excel('CPTAC3_Uterine_FollowUp_Outcome_8_12.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     NaN\n",
       "1     NaN\n",
       "2     NaN\n",
       "3     NaN\n",
       "4     NaN\n",
       "5     NaN\n",
       "6     NaN\n",
       "7     NaN\n",
       "8     NaN\n",
       "9     NaN\n",
       "10    NaN\n",
       "11    NaN\n",
       "12    NaN\n",
       "13    NaN\n",
       "14    NaN\n",
       "15    NaN\n",
       "16    NaN\n",
       "17    NaN\n",
       "18    NaN\n",
       "19    NaN\n",
       "20    NaN\n",
       "21    NaN\n",
       "22    NaN\n",
       "23    NaN\n",
       "24    NaN\n",
       "25    NaN\n",
       "26    NaN\n",
       "27    NaN\n",
       "28    NaN\n",
       "29    NaN\n",
       "       ..\n",
       "365   NaN\n",
       "366   NaN\n",
       "367   NaN\n",
       "368   NaN\n",
       "369   NaN\n",
       "370   NaN\n",
       "371   NaN\n",
       "372   NaN\n",
       "373   NaN\n",
       "374   NaN\n",
       "375   NaN\n",
       "376   NaN\n",
       "377   NaN\n",
       "378   NaN\n",
       "379   NaN\n",
       "380   NaN\n",
       "381   NaN\n",
       "382   NaN\n",
       "383   NaN\n",
       "384   NaN\n",
       "385   NaN\n",
       "386   NaN\n",
       "387   NaN\n",
       "388   NaN\n",
       "389   NaN\n",
       "390   NaN\n",
       "391   NaN\n",
       "392   NaN\n",
       "393   NaN\n",
       "394   NaN\n",
       "Name: Other New Tumor Procedure, Length: 395, dtype: float64"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "follow_up_df['Other New Tumor Procedure']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "living_filter = follow_up_df['Vital Status'] == 'Living'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "living_follow_up = follow_up_df[living_filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "deceased_follow_up = follow_up_df[~living_filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Case ID                                                           C3L-02894\n",
       "Follow-up Period                                                  12 Months\n",
       "Lost to Follow-up?                                                       No\n",
       "Vital Status                                                       Deceased\n",
       "Path Diag to Last Contact(Day)                                          428\n",
       "Cause of Death                                                          NaN\n",
       "Path Diag to Death(days)                                                431\n",
       "Adj Post-Op Radiation Therapy                                           Yes\n",
       "Adj Post-Op Pharma Therapy                                              Yes\n",
       "Adj Post-Op Immunotherapy                                                No\n",
       "Tumor Status                                                     With Tumor\n",
       "Menopausal Hormone Therapy                                          Unknown\n",
       "Oral Contraceptives                                                 Unknown\n",
       "Tamoxifen                                                           Unknown\n",
       "Hypertension                                                             No\n",
       "Diabetes                                                                 No\n",
       "Num Full Pregnancies                                                   None\n",
       "Colorectal Cancer                                                        No\n",
       "Success of Initial Treatment                             Persistent Disease\n",
       "Success of Treatment@ Followup                             Patient Deceased\n",
       "ECOG Score                         Not Evaluated: Not provided or available\n",
       "Karnofsky Score                    Not Evaluated: Not provided or available\n",
       "Perform Status Scale: Timing      Not Evaluated: Not provided or available.\n",
       "Other Perform Scale Timing                                              NaN\n",
       "New Tumor After Initial TRT                                              No\n",
       "Locoregional Recurrence Tumor                                           NaN\n",
       "Distant Metastasis Tumor                                                NaN\n",
       "New Primary Tumor                                                       NaN\n",
       "New Tumor Site Unknown                                                  NaN\n",
       "New Tumor Site Lung                                                     NaN\n",
       "New Tumor Site Bone                                                     NaN\n",
       "New Tumor Site Liver                                                    NaN\n",
       "New Tumor Site Brain                                                    NaN\n",
       "New Tumor Site Other                                                    NaN\n",
       "Specify Other New Tumor Site                                            NaN\n",
       "Path Diag to new Tumor (days)                                           NaN\n",
       "Additional Surgery ?                                                    NaN\n",
       "Path Diag to Surgery (days)                                             NaN\n",
       "New Tumor Procedure Unknown                                             NaN\n",
       "New Tumor Excisional biopsy                                             NaN\n",
       "New Tumor Incisional biopsy                                             NaN\n",
       "New Tumor Surgical Resection                                            NaN\n",
       "Other New Tumor Procedure                                               NaN\n",
       "Specify Other New Tumor Proc                                            NaN\n",
       "Residual Tumor After Surgery                                            NaN\n",
       "Radiation for New Tumor                                                 NaN\n",
       "Pharmaceutical for New Tumor                                            NaN\n",
       "Immunological for New Tumor                                             NaN\n",
       "Name: 209, dtype: object"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "deceased_follow_up.iloc[3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "persistent_filter = follow_up_df['Success of Initial Treatment'] == 'Persistent Disease'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "persistent_disease = follow_up_df[persistent_filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df = pd.read_csv('https://raw.githubusercontent.com/ruggleslab/blacksheep_supp/dev/vignettes/brca/phospho_common_samples_data.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "other = pd.read_csv('https://raw.githubusercontent.com/ruggleslab/blacksheep_supp/dev/vignettes/brca/annotations_common_samples.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(76, 24)"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
